Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) EPS (Weighted Average and Diluted) (2016 - 2025)

Pediatrix Medical (MD) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $0.4 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 8.11% to $0.4 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.94, a 263.03% increase, with the full-year FY2025 number at $1.94, up 263.03% from a year prior.
  • EPS (Weighted Average and Diluted) was $0.4 for Q4 2025 at Pediatrix Medical, down from $0.84 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.84 in Q3 2025 to a low of -$1.84 in Q2 2024.
  • A 5-year average of $0.12 and a median of $0.32 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 1020.0% in 2021, then crashed 641.18% in 2024.
  • Pediatrix Medical's EPS (Weighted Average and Diluted) stood at $0.56 in 2021, then tumbled by 35.71% to $0.36 in 2022, then plummeted by 516.67% to -$1.5 in 2023, then skyrocketed by 124.67% to $0.37 in 2024, then grew by 8.11% to $0.4 in 2025.
  • Per Business Quant, the three most recent readings for MD's EPS (Weighted Average and Diluted) are $0.4 (Q4 2025), $0.84 (Q3 2025), and $0.46 (Q2 2025).